INV16 17:15-17:45
Françoise Piguet, Inserm, Paris ⓘ
Gene therapy of Amyotrophic Lateral Sclerosis
INV17 17:45-18:15
Olivier Nègre, GCTi ⓘ
Gene and cell therapies: G&CTI, a think tank to face the multiple challenges
INV18 18:15-18:45
Thomas Roujeau, Hôtpital Gui de Chauliac, Montpellier ⓘ
Intracerebral gene therapy in 2 patients with aromatic-L acid decarboxylase (AADC) deficiency
OR11 18:45-19:00
Miryam Mebarki, Unité de Thérapie Cellulaire, Hôpital Saint-Louis, AP-HP
Development of a human umbilical cord-derived mesenchymal stromal cell (UC-MSC)-based advanced therapy medicinal product (ATMP) to treat immune and/or inflammatory diseases
OR12 19:00-19:15
Barbara Garmy-Susini, Inserm UMR1048
15-Lipoxygenase drives inflammation resolution and Treg trafficking in lymphedema